CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	8 Months Ended
	May 04, 2024	May 06, 2023
Cash flows from operating activities:
Net income	$ 1,760,219	$ 1,663,585
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property and equipment	374,416	339,087
Other non-cash (income) charges	(40,000)	74,000
Amortization of debt origination fees	8,155	6,065
Deferred income taxes	9,016	(3,424)
Share-based compensation expense	71,314	62,389
Changes in operating assets and liabilities:
Accounts receivable	(66,550)	38,317
Merchandise inventories	(353,813)	(93,163)
Accounts payable and accrued expenses	126,488	(239,900)
Income taxes	69,746	64,041
Other, net	(25,125)	(38,221)
Net cash provided by operating activities	1,933,866	1,872,776
Cash flows from investing activities:
Capital expenditures	(725,910)	(430,441)
Purchase of marketable debt securities	(17,551)	(48,445)
Proceeds from sale of marketable debt securities	21,245	37,544
Investment in tax credit equity investments	(193,327)	(50,685)
Other, net	(715)	13,051
Net cash used in investing activities	(916,258)	(478,976)
Cash flows from financing activities:
Net proceeds from commercial paper	631,300	524,000
Proceeds from issuance of debt	1,000,000	1,000,000
Repayment of debt	(300,000)	(300,000)
Net proceeds from sale of common stock	154,367	154,863
Purchase of treasury stock	(2,437,176)	(2,699,996)
Repayment of principal portion of finance lease liabilities	(62,455)	(60,927)
Other, net	(5,001)	(6,247)
Net cash used in financing activities	(1,018,965)	(1,388,307)
Effect of exchange rate changes on cash	(339)	5,043
Net (decrease)/increase in cash and cash equivalents	(1,696)	10,536
Cash and cash equivalents at beginning of period	277,054	264,380
Cash and cash equivalents at end of period	$ 275,358	$ 274,916